Clinical Outcomes After Viremia Among People Receiving Dolutegravir vs Efavirenz-Based First-line Antiretroviral Therapy in South Africa

BACKGROUND: We aimed to compare clinical outcomes after viremia between dolutegravir vs efavirenz-based first-line antiretroviral therapy (ART) as evidence is lacking outside clinical trials in resource-limited settings. METHODS: We conducted a retrospective cohort analysis with routine data from 59...

Descripción completa

Detalles Bibliográficos
Autores principales: Asare, Kwabena, Lewis, Lara, van der Molen, Johan, Sookrajh, Yukteshwar, Khubone, Thokozani, Moodley, Pravikrishnen, Lessells, Richard J, Naidoo, Kogieleum, Sosibo, Phelelani, Garrett, Nigel, Dorward, Jienchi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691652/
https://www.ncbi.nlm.nih.gov/pubmed/38045558
http://dx.doi.org/10.1093/ofid/ofad583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691652/
https://www.ncbi.nlm.nih.gov/pubmed/38045558
http://dx.doi.org/10.1093/ofid/ofad583

Ejemplares similares